secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001193125-24-215939
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis proposes public offering of common stock; no size or price disclosed
--------------------------------------------------------------------------

- Filed preliminary prospectus supplement on Sep 9, 2024 for a registered underwritten public offering of common stock.
- No specific number of shares, price range, or use of proceeds disclosed; offering subject to market conditions.
- Business update in supplement notes five marketed drugs, nine Phase 3 programs, and key milestones like olezarsen PDUFA Dec 19, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000119312524215939/0001193125-24-215939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000119312524215939/d881331d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-215939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer